Thu, Jan 29, 2015, 6:10 AM EST - U.S. Markets open in 3 hrs 20 mins

Recent

% | $
Quotes you view appear here for quick access.

Tesla Motors, Inc. (TSLA) Message Board

tony_naples 54 posts  |  Last Activity: Jan 22, 2015 3:28 PM Member since: Aug 13, 2003
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Look for up coming dividend cut.

    by ammpmmxway Jan 12, 2015 4:45 PM
    tony_naples tony_naples Jan 22, 2015 3:28 PM Flag

    Deepwater contracts are not renegotiable. Dayrates in the short run are not influenced by oil prices. The contracts at these levels are firm and the driller has lots of ways to enforce.
    Exxon or BP would try and renegotiate and thus harm their reputation. That would make future contract negotiations that much more difficult.

    Sentiment: Hold

  • tony_naples tony_naples Jan 22, 2015 10:40 AM Flag

    Not surprised if SDRL is the company...

  • tony_naples tony_naples Jan 20, 2015 5:19 PM Flag

    ABBV approval has nothing to do with GILD armor. Look at the script numbers and the new contracts. I'm sure ABBV will be successful overall as a company across all its products. Their success will not have a material effect on GILD. GILD continues to execute and increase sales regardless of the headline noise.

  • Reply to

    Why the biotech bubble may be bursting:

    by bearofbleecker Jan 13, 2015 3:24 PM
    tony_naples tony_naples Jan 14, 2015 7:52 PM Flag

    I disagree with your analysis. 50% discount on a 90% Gross margin product results in 80% gross margin.
    GILD revenue growth will continue with lower prices. Gross profit margin will be high as will net profit margin and net profit dollars. List price earns nothing in the first place. This has been true for 30 years in the enterprise technology space.

  • If you take any of the following medications you cannot take Ribovarin which is required for Abbvie HepC treatment. Consequently, Express Scripts must allow Harvoni or face litigation. Further if Express Scripts charges the patient more for the copay because it is not on formulary they will also face litigation.

    • VIEKIRA PAK and RBV drug interactions

    •MUST NOT TAKE VIEKIRA PAK IF YOU

    • take any of the following medicines:

    •alfuzosin hydrochloride (Uroxatral®) -
    •carbamazepine (Carbatrol®,
    •Epitol®,
    •Equetro®,
    •Tegretol®) - efavirenz
    •Sustiva®,
    •Atripla®) - ergot containing medicines including ergotamine tartrate
    •Cafergot®,
    •Migergot®,
    •Ergomar®,
    •Ergostat®,
    •Medihaler®,
    •Wigraine®,
    •Wigrettes®), dihydroergotamine mesylate
    •D.H.E. 45®,
    •Migranal®), methylergonovine
    •(Ergotrate®,
    •Methergine®) - ethinyl estradiol-containing medicines - gemfibrozil
    •(Lopid®) - lovastatin
    •Advicor®,
    •Altoprev®,
    •Mevacor®) - midazolam (when taken by mouth) - phenytoin
    •Dilantin®,
    •Phenytek®) - phenobarbital
    •Luminal®) - pimozide
    •Orap®) - rifampin
    •Rifadin®,
    •Rifamate®,
    •Rifater®,
    •Rimactane®) - sildenafil citrate
    •Revatio®) when taken for pulmonary artery hypertension (PAH) - simvastatin
    •Zocor®,
    •Vytorin®,
    •Simcor®) -
    •St. John's wort (Hypericum perforatum) or a product that contains St. John's wort - triazolam
    •Halcion®).


    •IF WITH RBV, THEN DONT TAKE VIEKIRA IF
    •YOU TAKE


    •The anti-HIV drug zidovudine (see fact sheet 411) can cause anemia and should not be combined with RBV.
    •and ALL THESE TOO:

    HIV and HCV are common in 25% of patients
    ◦abacavir
    ◦aldesleukin
    ◦aminophylline
    ◦antacids containing aluminum or magnesium
    ◦azathioprine
    ◦Chinese herbal medicine (sho-saiko-to or Xiao Chai Hu )
    ◦clozapine
    ◦didanosine
    ◦emtricitabine
    ◦influenza vaccine
    ◦lamivudine
    ◦methadone
    ◦pegloticase
    ◦stavudine
    ◦telbivudine
    ◦tenofovir
    ◦theophylline
    ◦zidovudine

  • tony_naples by tony_naples Dec 16, 2014 1:46 PM Flag

    This movement is not untypical for volatile UBNT. If we see it break 35 during this run then we have real up movement...

  • tony_naples tony_naples Dec 16, 2014 1:26 PM Flag

    I agree. This a bear market rally in the oil industry. Some of the best rallys are in a bear market.

  • Reply to

    BUYING OPPORTUNITY

    by lrmd50 Dec 12, 2014 7:20 AM
    tony_naples tony_naples Dec 12, 2014 4:00 PM Flag

    ZACKS strong buy means BRK will go down. Fair price, but more interesting in the 130s

  • Reply to

    oversold by 30-50%

    by bilbo79 Dec 1, 2014 7:40 PM
    tony_naples tony_naples Dec 10, 2014 5:46 PM Flag

    I don't want to buy rigs at $0.40 on the $1. I want positive cash flow after debt payment. EBITDA is of no interest. PACD will not be sold, so the only value is determining future earnings and cash flows. Long term PACD is a solid company with solid mgmt. great reputation, high spec rigs in the UDW space.

  • Reply to

    Response to why management bought shares.

    by jdsomers Dec 8, 2014 11:07 AM
    tony_naples tony_naples Dec 8, 2014 11:39 AM Flag

    Then you are trader and not investor. That is risk you take. PSEC is poor trading company.
    The company is designed to return dividends to long term shareholders over time. I sold 95% of my PSEC since I don't trust mgmt. as I once did.

  • tony_naples tony_naples Dec 8, 2014 9:56 AM Flag

    Analysts cannot defend a lawsuit. Arista will have the lawsuit as an overhang until the suit is settled.
    The company will do well as it always has in the market. The stock will stay within a trading range IMO.

  • Reply to

    I have a Jan 2014 110 call

    by peavel Dec 5, 2014 12:18 PM
    tony_naples tony_naples Dec 5, 2014 2:33 PM Flag

    If you need to ask then you shouldn't buy options, especially if you asking on a public board with majority of posters who have little credibility or transparency.

  • tony_naples tony_naples Dec 5, 2014 1:44 PM Flag

    You guys are foolish traders talking about your skill and long term investing skills.
    This company will not fold. If you think it will then provide detailed support for your thesis. Otherwise you and synch are just talk no analysis.

  • tony_naples tony_naples Dec 5, 2014 1:41 PM Flag

    I'm not waiting on the dividend. This is capital appreciation play from the bottom. As dividend players migrate out value players will buy-in starting in 1st qtr. 2015. I'm familiar with crude and this CEO. The company is well positioned now to weather the next 2 years. D/E is 100 and will decrease as suspended dividend pays down debt. You don't present any specific knowledge of the offshore drilling market or an understanding of European stocks. Why you would say contracts are meaningless in a market valued by projected firm contract revenue demonstrates your ignorance of offshore. This is cyclical industry that is hitting near bottom in 90 day period that has firm revenue through 2016.
    The revenue and expenses are clearly set and can only go up by the company closing new contracts for new builds. They have 18-24 months to close those agreements. Until you demonstrate specific knowledge of this industry your generalized statements are meaningless.
    The dividend play in this industry is SDLP, but you would probably argue against that given your limited knowledge of this industry and the financial structure.

  • Reply to

    somethings up !!

    by hibuck1 Dec 3, 2014 4:54 PM
    tony_naples tony_naples Dec 5, 2014 11:37 AM Flag

    They are shifting to a software NFV model to replace hardware. While the margins are high in software, the actual revenue number decreases substantially. The major service providers like VZN are where they want to get huge revenue and they are betting big money they can take share from Cisco and Juniper in that space. I'm skeptical, especially with such a long sell cycle. The expense side, the dividends and the buy backs are all positive. The revenue is key. If they don't grow this year then they will be discounted as a player in IP. I see better opportunities.

  • tony_naples tony_naples Dec 5, 2014 11:02 AM Flag

    Yes I'm naive to think JF will change his pattern of operating his companies. How familiar are you with ownership structure of SDRL? How familiar are you with European model of treating dividends? Do you know the contract structure for SDRL for the next 2 years with projected cash flows? How long have you been investing with offshore oil companies? This is not a US REIT or holding company like ACAS.

  • Reply to

    Scripts

    by jackwomble7 Dec 5, 2014 10:24 AM
    tony_naples tony_naples Dec 5, 2014 10:55 AM Flag

    Where is your source for the data? I'm trying to confirm

  • tony_naples tony_naples Dec 5, 2014 10:48 AM Flag

    SDRL is not a US company. They grew because of debt. They have started to fix the balance sheet with D/E of 100 today. The dividend cut will be used to pay down debt. As a European company they will bring back the dividend in 24-36 months. Europeans treat dividends much differently than US. When offshore drilling comes back the debt and dividends will follow in this company.

  • Reply to

    Market punishing us

    by typea1949 Dec 5, 2014 6:31 AM
    tony_naples tony_naples Dec 5, 2014 9:49 AM Flag

    This is rotation of dividend investors out of a stock that suspended dividends exacerbated by a poor market outlook. The selling is expected. The value investors will come into SDRL in January. Until then the trend will be down.

  • Reply to

    somethings up !!

    by hibuck1 Dec 3, 2014 4:54 PM
    tony_naples tony_naples Dec 3, 2014 6:04 PM Flag

    BRCD has flat IP product revenues. That is the future of the business. SAN is a great cash cow, but no one highly values technology companies with no growth. The EPS growth is all based on stock buy backs. That will only go so far. 2015 is the year BRCD must increase revenue growth substantially or this will be a $6 stock again. Then someone may acquire them for the cash cow.

TSLA
199.37-6.610(-3.21%)Jan 28 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NASDAQWed, Jan 28, 2015 4:00 PM EST
Nokia Corporation
NYSEWed, Jan 28, 2015 4:01 PM EST